top of page

i&i Bio, the newly estabilished investment fund powered by i&i Prague and EIF

založení fondu.jpg
It is our pleasure to announce the start of operations of i&i Biotech Fund (i&i Bio) in September 2021. This is a great success of i&i Prague team and it brings a new quality and a unique opportunity for early-phase deep-tech spin-offs in Czechia and rest of the Europe. i&i Bio focuses on unique technologies in the fields of Medtech, Diagnostics and Drug discovery. i&i Bio manages more than 45 million EUR and the fund is prepared to invest an average of 2 million EUR (more than 50 million CZK) in a specific project, but in exceptional cases the amount may grow to as much as 4.5 million EUR for a single project.

The fund will be joined by further investors in near future including CUIP, the daughter company of the Charles University in Prague.

Further details and press release could be found here!

About i&i Bio

i&i Bio is a Luxembourg-based venture capital firm that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics, and digital health. The Fund was created thanks to the cooperation of the biotech incubator i&i Prague and the European Investment Fund (see below). With over €45M under management, i&i Bio plans to invest in about 20 early-stage companies. i&i Bio is led by an experienced team of professionals with backgrounds in private equity, healthcare and venture capital supporting entrepreneurs on their journey to global success. Thanks to the close cooperation with the fund’s sponsor, the biotech academic incubator i&i Prague, i&i Bio is supporting and advancing transformative Central European technology companies. For more information visit

Kopie i&i_bio_logotyp-03_edited.jpg

About European Investment Fund

i&i Bio is supported by an investment from the EIF, with the support of:

  • lnnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing; and

  • the Pan-European Guarantee Fund (EGF), implemented by the EIF with the financial support of the Participating Member States. The objective of EGF is to respond to the economic impact of the COVID-19 pandemic by ensuring that companies in the Participating Member States have sufficient short-term liquidity available to weather the crisis and are able to continue their growth and development in the medium to long-term.

Kopie eif web2_edited_edited.jpg
bottom of page